slideshow
Special Report
video
slideshow
Special Report
video
Arlene Weintraub
Arlene Weintraub was named a senior writer for BusinessWeek's Science & Technology department in September 2007.
Weintraub joined BusinessWeek's Los Angeles bureau in 2000, covering info tech and biotech, and moved to the Sci-Tech team in New York in 2004. She has produced a string of cover stories, elegant features, and investigative pieces. Her 2006 cover story "Forever Young" won awards from the New York Press Club and Association of Health Care Journalists. She received an American Society of Business Publication Editors Gold Award in feature writing for the 2004 cover story "I Can't Sleep."
Prior to joining Businessweek, Weintraub was a senior editor at P.O.V. magazine in New York, where she wrote about a wide variety of issues, including e-commerce. Weintraub also worked at Home Office Computing, Individual Investor, and Tucson Lifestyle magazines, and she contributed stories about business and finance to a number of publications, including The New York Times.
Weintraub received her bachelor's degree from the University of Pennsylvania and is a graduate of Medill School of Journalism at Northwestern University. In her spare time, she plays oboe and flute in chamber music groups.
Recent Articles by Arlene Weintraub
April 8, 2010
Diabetes Is No Fun, but It Can Be a Game
Luke Wessel was four years old when he figured out how to hide the glucose meter his parents used to monitor his diabetes. He associated the device with uncomfortable ...
February 24, 2010
Eli Lilly's Drug Assembly Line
Shortly after becoming CEO of Eli Lilly (LLY) in April 2008, John Lechleiter, a former lab scientist, sent senior executives a gift. It was a digital clock counting ...
February 3, 2010
Take Your Meds, Exercise—and Spend Billions
A decade ago General Electric (GE) experimented with a promising approach to employee health care known as disease management. It hired a company to talk with workers ...
February 3, 2010
Swine Flu: The Pandemic That Wasn't
The swine flu pandemic didn't turn out to be the scourge international health agencies predicted. On Jan. 29 the World Health Organization declared that even though ...
December 9, 2009
The New Prominence of Comparative Drug Trials
Roche announced on Dec. 2 that its experimental diabetes drug performed better in a trial than Merck's (MRK) $2 billion-a-year blockbuster Januvia. This gave the Swiss...
November 24, 2009
Can Roche Leave Genentech Alone?
Pascal Soriot, a senior executive with Roche (RHHBY), says he was wracked with anxiety while boarding a plane from Basel, Switzerland, to San Francisco last March. The...
November 11, 2009
New Weapons in Medicine
When Kazumi Shiosaki is explaining the science behind her biotech startup, Epizyme, to investors, she uses a piano analogy. The keys, she says, are like genes: They're...
November 4, 2009
Brain Workouts
Can games prevent cognitive decline? Several companies think they might. Posit Science sells the Brain Fitness Program for PCs for $395, and there's Brain Age for ...
November 4, 2009
Elder Care by Remote
For three months early this year, 63-year-old Ronald Lang was one of the most plugged-in patients in America. Lang, who suffers from congestive heart failure and ...
November 3, 2009
Ask Your Doctor If This Ad Is Right for You
Does it seem like you hear the phrase "ask your doctor" every time you turn on the TV? There's a reason. Drug companies spend about $5 billion a year in the U.S. on ...
